Functional outcomes after organ preservation treatment in head and neck cancer: a critical review of the literature

International Journal of Oral and Maxillofacial Surgery

Volumn 35, Issue 7, 2006, Pages 581-587

  Rieger, J M ^a,b   Zalmanowitz, J G ^a,b   Wolfaardt, J F ^a,b  

^a Craniofacial Osseointegration and Maxillofacial Prosthetic Rehabilitation Unit (COMPRU)   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; ASPIRATION; CANCER RADIOTHERAPY; CINAHL; COCHRANE LIBRARY; DYSPHAGIA; EMBASE; ENTERIC FEEDING; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; LARYNX DISORDER; MANDIBLE CANCER; MAXILLA CANCER; MEDICAL LITERATURE; MEDLINE; MOUTH CANCER; NASOPHARYNX CANCER; OROPHARYNX CANCER; OUTCOME ASSESSMENT; PHARYNX DISEASE; QUALITY OF LIFE; REVIEW; SPEECH DISORDER; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHILD; CRANIAL IRRADIATION; DEGLUTITION DISORDERS; ENTERAL NUTRITION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, ASPIRATION; QUALITY OF LIFE; SPEECH DISORDERS; XEROSTOMIA;

EID: 33745006632     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2006.03.026     Document Type: Review

References (68)

1. Ackerstaff A.H., Tan I.B., Rasch C.R., Balm A.J., Keus R.B., Schornagel J.H., and Hilgers F.J. Quality-of-life assessment after supradose selective intra-arterial cisplatin and concomitant radiation (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 128 (2002) 1185-1190
2. Adelstein D.J., Saxton J.P., Lavertu P., Tuason L., Wood B.G., Wanamaker J.R., Eliachar I., Strome M., and Van Kirk M.A. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 19 (1997) 567-575
3. Allal A.S., Nicoucar K., Mach N., and Dulguerov P. Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy. Head Neck 25 (2003) 833-840
4. Argiris A. Update on chemoradiotherapy for head and neck cancer. Curr Opin Oncol 14 (2002) 323-329
5. Barrett W.L., Gluckman J.L., Wilson K.M., and Gleich L.L. A comparison of treatments of squamous cell carcinoma of the base of tongue: surgical resection combined with external radiation therapy, external radiation therapy alone, and external radiation therapy combined with interstitial radiation. Brachytherapy 3 (2004) 240-245
6. Bernier J., Domenge C., Ozsahin M., Matuszewska K., Lefebvre J.L., Greiner R.H., Giralt J., Maingon P., Rolland F., Bolla M., Cognetti F., Bourhis J., Kirkpatrick A., and van Glabbeke M. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 (2004) 1945-1952
7. Bjordal K., Kaasa S., and Mastekaasa A. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys 28 (1994) 847-856
8. Boyle J., Patel S., and Shah J.P. Management of oral and oropharyngeal cancers. Oral Dis 9 (2003) 109-111
9. Bundgaard T., Tandrup O., and Elbrond O. A functional evaluation of patients treated for oral cancer. a prospective study. Int J Oral Maxillofac Surg 22 (1993) 28-34
10. Campbell B.H., Marbella A., and Layde P.M. Quality of life and recurrence concern in survivors of head and neck cancer. Laryngoscope 110 (2000) 895-906
11. Carvalho A.L., Magrin J., and Kowalski L.P. Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach. Oral Dis 9 (2003) 112-118
12. Cella D.F., Tulsky D.S., Gray G., Sarafian B., Linn E., Bonomi A., Silberman M., Yellen S.B., Winicour P., and Brannon J. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11 (1993) 570-579
13. Cooper J.S., Pajak T.F., Forastiere A.A., Jacobs J., Campbell B.H., Saxman S.B., Kish J.A., Kim H.E., Cmelak A.J., Rotman M., Machtay M., Ensley J.F., Chao K.S., Schultz C.J., Lee N., and Fu K.K. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 (2004) 1937-1944
14. Eisbruch A., Lyden T., Bradford C.R., Dawson L.A., Haxer M.J., Miller A.E., Teknos T.N., Chepeha D.B., Hogikyan N.D., Terrell J.E., and Wolf G.T. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 53 (2002) 23-28
15. EORTC Protocol 15941. Cited in Fayers P, Aaronson N, Bjordal K, Curran D, Groenvold M. EORTC QLQ Scoring Manual. Brussels: Quality of Life Study Group of the European Organisation for Research and Treatment of Cancer 1999.
16. Epstein J.B., Emerton S., Kolbinson D.A., Le N.D., Phillips N., Stevenson-Moore P., and Osoba D. Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 21 (1999) 1-11
17. Gillespie M.B., Brodsky M.B., Day T.A., Lee F.S., and Martin-Harris B. Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope 114 (2004) 1362-1367
18. Glicksman A.S., Wanebo H.J., Slotman G., Liu L., Landmann C., Clark J., Zhu T.C., Lohri A., and Probst R. Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 39 (1997) 721-729
19. Graner D.E., Foote R.L., Kasperbauer J.L., Stoeckel R.E., Okuno S.H., Olsen K.D., Sabri A.N., Maragos N.E., Cha S.S., Sargent D.J., and Strome S.E. Swallow function in patients before and after intra-arterial chemoradiation. Laryngoscope 113 (2003) 573-579
20. Hamlet S., Faull J., Klein B., Aref A., Fontanesi J., Stachler R., Shamsa F., Jones L., and Simpson M. Mastication and swallowing in patients with postirradiation xerostomia. Int J Radiat Oncol Biol Phys 37 (1997) 789-796
21. Hammerlid E., Mercke C., Sullivan M., and Westin T. A prospective quality of life study of patients with oral or pharyngeal carcinoma treated with external beam irradiation with or without brachytherapy. Oral Oncol 33 (1997) 189-196
22. Haraf D.J., Rosen F.R., Stenson K., Argiris A., Mittal B.B., Witt M.E., Brockstein B.E., List M.A., Portugal L., Pelzer H., Weichselbaum R.R., and Vokes E.E. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer. Clin Cancer Res 9 (2003) 5936-5943
23. Harrison L.B., Zelefsky M.J., Armstrong J.G., Carper E., Gaynor J.J., and Sessions R.B. Performance status after treatment for squamous cell cancer of the base of tongue-a comparison of primary radiation therapy versus primary surgery. Int J Radiat Oncol Biol Phys 30 (1994) 953-957
24. Harrison L.B., Zelefsky M.J., Pfister D.G., Carper E., Raben A., Kraus D.H., Strong E.W., Rao A., Thaler H., Polyak T., and Portenoy R. Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck 19 (1997) 169-175
25. Hassan S.J., and Weymuller Jr. E.A. Assessment of quality of life in head and neck cancer patients. Head Neck 15 (1993) 485-496
26. Horwitz E.M., Frazier A.J., Martinez A.A., Keidan R.D., Clarke D.H., Lacerna M.D., Gustafson G.S., Heil E., Dmuchowski C.F., and Vicini F.A. Excellent functional outcome in patients with squamous cell carcinoma of the base of tongue treated with external irradiation and interstitial iodine 125 boost. Cancer 78 (1996) 948-957
27. Huguenin P., Glanzmann C., Taussky D., Lutolf U.M., Schmid S., and Moe K. Hyperfractionated radiotherapy and simultaneous cisplatin for stage-III and -IV carcinomas of the head and neck. Long-term results including functional outcome. Strahlenther Onkol 174 (1998) 397-402
28. Huguenin P.U., Taussky D., Moe K., Meister A., Baumert B., Lutolf U.M., and Glanzmann C. Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: the importance of the target volume. Int J Radiat Oncol Biol Phys 45 (1999) 47-52
29. Kendall K.A., McKenzie S.W., Leonard R.J., and Jones C. Structural mobility in deglutition after single modality treatment of head and neck carcinomas with radiotherapy. Head Neck 20 (1998) 720-725
30. Kendall K.A., McKenzie S.W., Leonard R.J., and Jones C.U. Timing of swallowing events after single-modality treatment of head and neck carcinomas with radiotherapy. Ann Otol Rhinol Laryngol 109 (2000) 767-775
31. Khan K.S., Kunz R., Kleijnen J., and Antes G. Systematic Reviews to Support Evidence-based Medicine: How to Review and Apply Findings of Healthcare Research (2003), Royal Society of Medicine Press, Lake Forest, IL
32. Kies M.S., Haraf D.J., Rosen F., Stenson K., List M., Brockstein B., Chung T., Mittal B.B., Pelzer H., Portugal L., Rademaker A., Weichselbaum R., and Vokes E.E. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 19 (2001) 1961-1969
33. Koch W.M., Lee D.J., Eisele D.W., Miller D., Poole M., Cummings C.W., and Forastiere A. Chemoradiotherapy for organ preservation in oral and pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 121 (1995) 974-980
34. Kotz T., Abraham S., Beitler J.J., Wadler S., and Smith R.V. Pharyngeal transport dysfunction consequent to an organ-sparing protocol. Arch Otolaryngol Head Neck Surg 125 (1999) 410-413
35. Kotz T., Costello R., Li Y., and Posner M.R. Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck 26 (2004) 365-372
36. Lazarus C.L. Management of swallowing disorders in head and neck cancer patients: optimal patterns of care. Semin Speech Lang 21 (2000) 293-309
37. Lazarus C.L., Logemann J.A., Pauloski B.R., Colangelo L.A., Kahrilas P.J., Mittal B.B., and Pierce M. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope 106 (1996) 1157-1166
38. Leyvraz S., Pasche P., Bauer J., Bernasconi S., and Monnier P. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study. J Clin Oncol 12 (1994) 1876-1885
39. List M.A., and Bilir S.P. Functional outcomes in head and neck cancer. Semin Radiat Oncol 14 (2004) 178-189
40. List M.A., and Bilir S.P. Evaluations of quality of life and organ function. Semin Oncol 31 (2004) 827-835
41. List M.A., Mumby P., Haraf D., Siston A., Mick R., MacCracken E., and Vokes E. Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer. Qual Life Res 6 (1999) 274-284
42. List M.A., Ritter-Sterr C., and Lansky S.B. A performance status scale for head and neck cancer patients. Cancer 66 (1990) 564-569
43. List M.A., Siston A., Haraf D., Schumm P., Kies M., Stenson K., and Vokes E.E. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol 17 (1999) 1020-1028
44. Logemann J.A., Pauloski B.R., Rademaker A.W., Lazarus C.L., Mittal B., Gaziano J., Stachowiak L., MacCracken E., and Newman L.A. Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck 25 (2003) 432-437
45. Magne N., Marcy P.Y., Chamorey E., Guardiola E., Pivot X., Schneider M., Demard F., and Bensadoun R.J. Concomitant twice-a-day radiotherapy and chemotherapy in unresectable head and neck cancer patients: A long-term quality of life analysis. Head Neck 23 (2001) 678-682
46. Malone J.P., Stephens J.A., Grecula J.C., Rhoades C.A., Ghaheri B.A., and Schuller D.E. Disease control, survivial, and functional outcomes after multimodal treatment for advanced-stage tongue base cancer. Head Neck 26 (2004) 561-572
47. Mantovani G., Gebbia V., Proto E., Cossu F., Bianchi A., Curreli L., Ghiani M., Astara G., Lampis B., Dessi D., Santona M.C., and Massa E. Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer: a tentative quantitative evaluation of organ preservation and clinical response. Int J Clin Oncol 9 (1996) 571-578
48. McDonough E.M., Varvares M.A., Dunphy F.R., Dunleavy T., Dunphy C.H., and Boyd J.H. Changes in quality-of-life scores in a population of patients treated for squamous cell carcinoma of the head and neck. Head Neck 18 (1996) 487-493
49. Mittal B.B., Pauloski B.R., Haraf D.J., Pelzer H.J., Argiris A., Vokes E.E., Rademaker A., and Logemann J.A. Swallowing dysfunction-preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int J Radiat Oncol Biol Phys 57 (2003) 1219-1230
50. Moore A., McQuay A., and Gray J.A.M. Evidence-based everything. Bandolier 12 (1995) 1
51. Moore G.J., Parsons J.T., and Mendenhall W.M. Quality of life outcomes after primary radiotherapy for squamous cell carcinoma of the base of tongue. Int J Radiat Oncol Biol Phys 36 (1996) 351-354
52. Morton R.P. Studies in the quality of life of head and neck cancer patients: results of a two-year longitudinal study and a comparative cross-sectional cross-cultural survey. Laryngoscope 113 (2003) 1091-1103
53. Munter M.W., Karger C.P., Hoffner S.G., Hof H., Thilmann C., Rudat V., Nill S., Wannemacher M., and Debus J. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Head Neck 58 (2004) 175-184
54. Murry T., Madasu R., Martin A., and Robbins K.T. Acute and chronic changes in swallowing and quality of life following intraarterial chemoradiation for organ preservation in patients with advanced head and neck cancer. Head Neck 20 (1998) 31-37
55. Newman L.A., Robbins K.T., Logemann J.A., Rademaker A.W., Lazarus C.L., Hamner A., Tusant S., and Huang C.F. Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation. Head Neck 24 (2002) 68-77
56. Newman L.A., Vieira F., Schwiezer V., Samant S., Murry T., Woodson G., Kumar P., and Robbins K.T. Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 124 (1998) 589-592
57. Pauloski B.R., Rademaker A.W., Logemann J.A., Lazarus C.L., Newman L., Hamner A., MacCracken E., Gaziano J., and Stachowiak L. Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck 24 (2002) 555-565
58. Pourel N., Peiffert D., Lartigau E., Desandes E., Luporsi E., and Conroy T. Quality of life in long-term survivors of oropharynx carcinoma. Int J Radiat Oncol Biol Phys 54 (2002) 742-751
59. Saarilahti K., Kouri M., Collan J., Hamalainen T., Atula T., Joensuu H., and Tenhunen M. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol 74 (2005) 251-258
60. Sessions D.G., Lenox J., Spector G.J., Chao C., and Chaudry O.A. Analysis of treatment results for base of tongue cancer. Laryngoscope 113 (2003) 1252-1261
61. Smith R.V., Goldman S.Y., Beitler J.J., and Wadler S.S. Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 130 (2004) 831-836
62. Smith R.V., Kotz T., Beitler J.J., and Wadler S. Long-term swallowing problems after organ preservation therapy with concomitant radiation therapy and intravenous hydroxyurea: initial results. Arch Otolaryngol Head Neck Surg 126 (2000) 384-389
63. Sunwoo J.B., Herscher L.L., Kroog G.S., Thomas G.R., Ondrey F.G., Duffey D.C., Solomon B.I., Boss C., Albert P.S., McCullugh L., Rudy S., Muir C., Zhai S., Figg W.D., Cook J.A., Mitchell J.B., and Van Waes C. Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer. J Clin Oncol 19 (2001) 800-811
64. Tishler R.B., Busse P.M., Norris Jr. C.M., Rossi R., Poulin M., Thornhill L., Costello R., Peters E.S., Colevas A.D., and Posner M.R. An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies. Int J Radiat Oncol Biol Phys 43 (1999) 1001-1008
65. Tschudi D., Stoeckli S., and Schmid S. Quality of life after different treatment modalities for carcinoma of the oropharynx. Laryngoscope 113 (2003) 1949-1954
66. Vartanian J.G., Carvalho A.L., Yueh B., Priante A.V., de Melo R.L., Correia L.M., Kohler H.F., Toyota J., Kowalski I.S., and Kowalski L.P. Long-term quality-of-life evaluation after head and neck cancer treatment in a developing country. Arch Otolaryngol Head Neck Surg 130 (2004) 1209-1213
67. Vokes E.E., Kies M.S., Haraf D.J., Stenson K., List M., Humerickhouse R., Dolan M.E., Pelzer H., Sulzen L., Witt M.E., Hsieh Y.C., Mittal B.B., and Weichselbaum R.R. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol 18 (2000) 1652-1661
68. Vokes E.E., Stenson K., Rosen F.R., Kies M.S., Rademaker A.W., Witt M.E., Brockstein B.E., List M.A., Fung B.B., Portugal L., Mittal B.B., Pelzer H., Weichselbaum R.R., and Haraf D.J. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 21 (2003) 320-326